Gumda, Mohammad .

HRN: 14-86-72  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2025
CO-AMOXICLAV 625MG (TAB)
05/08/2025
05/15/2025
PO
625mg
Tid
CAP LR
Waiting Final Action 
05/09/2025
CEFTRIAXONE 1G (VIAL)
05/09/2025
05/16/2025
IV
2g
OD
CAP LR; T/c Septic Arthritis
Waiting Final Action 
05/11/2025
CEFIXIME 200MG (CAP)
05/11/2025
05/18/2025
ORAL
1 Tab
BID
CAP LR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: